0001209191-19-026572.txt : 20190430 0001209191-19-026572.hdr.sgml : 20190430 20190430163357 ACCESSION NUMBER: 0001209191-19-026572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190426 FILED AS OF DATE: 20190430 DATE AS OF CHANGE: 20190430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novak Alfred J CENTRAL INDEX KEY: 0001388862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38135 FILM NUMBER: 19782330 MAIL ADDRESS: STREET 1: 325 NE 6TH ST CITY: BOCA RATON STATE: FL ZIP: 33432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001685071 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 919-806-4487 MAIL ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 FORMER COMPANY: FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20160919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-26 0 0001685071 Dova Pharmaceuticals Inc. DOVA 0001388862 Novak Alfred J C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707 1 0 0 0 Stock Option (right to buy) 9.36 2019-04-26 4 A 0 10000 0.00 A 2029-04-25 Common Stock 10000 10000 D Vesting monthly over one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders, subject to continued service as a director though the applicable vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2019-04-30